Hangzhou Tigermed Consulting Co., Ltd

SZSE:300347 Stok Raporu

Piyasa değeri: CN¥49.0b

Hangzhou Tigermed Consulting Gelecekteki Büyüme

Future kriter kontrolleri 3/6

Hangzhou Tigermed Consulting kazanç ve gelirin sırasıyla yıllık 36.1% ve 13.4% oranında artacağı tahmin edilmektedir. EPS'nin yıllık 36% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde 8.5% olacağı tahmin edilmektedir.

Anahtar bilgiler

36.1%

Kazanç büyüme oranı

36.0%

EPS büyüme oranı

Life Sciences kazanç büyümesi31.7%
Gelir büyüme oranı13.4%
Gelecekteki özkaynak getirisi8.5%
Analist kapsamı

Good

Son güncelleme20 Nov 2024

Gelecekteki son büyüme güncellemeleri

Hangzhou Tigermed Consulting Co., Ltd Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Apr 28
Hangzhou Tigermed Consulting Co., Ltd Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Recent updates

Hangzhou Tigermed Consulting Co., Ltd's (SZSE:300347) Share Price Could Signal Some Risk

Aug 21
Hangzhou Tigermed Consulting Co., Ltd's (SZSE:300347) Share Price Could Signal Some Risk

Hangzhou Tigermed Consulting (SZSE:300347) Is Increasing Its Dividend To CN¥0.568

Jul 12
Hangzhou Tigermed Consulting (SZSE:300347) Is Increasing Its Dividend To CN¥0.568

Is Hangzhou Tigermed Consulting (SZSE:300347) A Risky Investment?

Jun 26
Is Hangzhou Tigermed Consulting (SZSE:300347) A Risky Investment?

An Intrinsic Calculation For Hangzhou Tigermed Consulting Co., Ltd (SZSE:300347) Suggests It's 35% Undervalued

Jun 07
An Intrinsic Calculation For Hangzhou Tigermed Consulting Co., Ltd (SZSE:300347) Suggests It's 35% Undervalued

Hangzhou Tigermed Consulting Co., Ltd Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Apr 28
Hangzhou Tigermed Consulting Co., Ltd Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Hangzhou Tigermed Consulting Co., Ltd (SZSE:300347) Stock Catapults 27% Though Its Price And Business Still Lag The Market

Apr 08
Hangzhou Tigermed Consulting Co., Ltd (SZSE:300347) Stock Catapults 27% Though Its Price And Business Still Lag The Market

Hangzhou Tigermed Consulting's (SZSE:300347) Profits Appear To Have Quality Issues

Apr 04
Hangzhou Tigermed Consulting's (SZSE:300347) Profits Appear To Have Quality Issues

Hangzhou Tigermed Consulting Co., Ltd Just Missed Earnings - But Analysts Have Updated Their Models

Apr 01
Hangzhou Tigermed Consulting Co., Ltd Just Missed Earnings - But Analysts Have Updated Their Models

Kazanç ve Gelir Büyüme Tahminleri

SZSE:300347 - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (CNY Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
12/31/20269,6182,2731,6562,16620
12/31/20258,4461,9411,6071,95622
12/31/20246,9081,2741,2141,58010
9/30/20246,8019596781,057N/A
6/30/20247,0311,129594953N/A
3/31/20247,2401,6919241,266N/A
12/31/20237,3842,0258371,150N/A
9/30/20237,3302,2818661,205N/A
6/30/20237,2022,2039641,373N/A
3/31/20237,0722,0576131,083N/A
1/1/20237,0852,0079091,358N/A
9/30/20227,2252,6981,0981,521N/A
6/30/20226,7512,8119171,299N/A
3/31/20226,1292,9371,1891,489N/A
1/1/20225,2142,8741,0551,424N/A
9/30/20214,2872,2139301,210N/A
6/30/20213,7972,0069761,263N/A
3/31/20213,4441,9508951,148N/A
12/31/20203,1921,750842999N/A
9/30/20203,0731,632558704N/A
6/30/20202,9181,488524621N/A
3/31/20202,845951452565N/A
12/31/20192,803842425528N/A
9/30/20192,737682386518N/A
6/30/20192,605606356450N/A
3/31/20192,436522387488N/A
12/31/20182,301472431522N/A
9/30/20182,107419458521N/A
6/30/20181,977400N/A404N/A
3/31/20181,805354N/A312N/A
12/31/20171,687301N/A315N/A
9/30/20171,500241N/A272N/A
6/30/20171,352182N/A281N/A
3/31/20171,255144N/A305N/A
12/31/20161,175141N/A192N/A
9/30/20161,150145N/A176N/A
6/30/20161,096159N/A156N/A
3/31/20161,015161N/A135N/A
12/31/2015957156N/A186N/A
9/30/2015862151N/A98N/A
6/30/2015821147N/A100N/A
3/31/2015725135N/A87N/A
12/31/2014625125N/A44N/A
9/30/2014510112N/A46N/A
6/30/2014401102N/A59N/A
3/31/201437799N/A57N/A
12/31/201333794N/A77N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: 300347 'nin tahmini kazanç büyümesi (yıllık 36.1% ) tasarruf oranının ( 2.8% ) üzerindedir.

Kazançlar ve Piyasa: 300347 şirketinin kazançlarının (yıllık 36.1% ) CN pazarından (yıllık 26.2% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Kazançları: 300347 şirketinin kazançlarının önümüzdeki 3 yıl içerisinde önemli ölçüde artması bekleniyor.

Gelir ve Pazar: 300347 şirketinin gelirinin (yıllık 13.4% ) CN pazarından (yıllık 13.9% ) daha yavaş büyümesi öngörülüyor.

Yüksek Büyüme Geliri: 300347 şirketinin gelirinin (yıllık 13.4% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.


Hisse Başına Kazanç Büyüme Tahminleri


Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: 300347 'nin Özsermaye Getirisi'nin 3 yıl içinde düşük olması tahmin ediliyor ( 8.5 %).


Büyüyen şirketleri keşfedin